<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03457298</url>
  </required_header>
  <id_info>
    <org_study_id>0014-18-RMB CTIL</org_study_id>
    <nct_id>NCT03457298</nct_id>
  </id_info>
  <brief_title>Lateral Ridge Augmentation Using a Volume Maintaining Collagen Scaffold Versus Allograft With Collagen Membrane.</brief_title>
  <official_title>Lateral Ridge Augmentation Using a Volume Maintaining Collagen Scaffold (Ossix Volumax) Versus Freeze-dried Bone Allograft (FDBA) With Collagen Membrane</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rambam Health Care Campus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the current study is to compare lateral bone augmentation using the current gold
      standard (FDBA plus resorbable collagen membrane) versus Ossix Volumax as a stand-alone
      material.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One of the major problems in implant therapy is the need to regenerate bone after its
      resorption because of periodontal disease, traumatic extraction or surgical removal
      associated with treatment of invasive lesions.

      Ossix Volumax is a novel volume maintaining collagen scaffold designed for bone augmentation
      in the atrophic ridge. It is 1-2 mm in thickness and undergoes mineralization progressing
      into ossification.

      Thirty subjects requiring lateral bone augmentation of the maxilla or the mandible will be
      recruited study: Of these, twenty will be recruited and treated at the School of Dental
      Medicine, Harvard University, Boston, USA and ten (10) at the School of Graduate Dentistry,
      Rambam health care campus, Haifa, Israel.

      Hypothesis:

      The use of Ossix Volumax as a stand-alone augmentation material will results similar increase
      in the ridge width and volume compared to FDBA and barrier membrane when coupled together.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2018</start_date>
  <completion_date type="Anticipated">July 2020</completion_date>
  <primary_completion_date type="Anticipated">April 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in socket width mm</measure>
    <time_frame>baseline( prior to augmentation) and 9 months (implant placement)</time_frame>
    <description>Clinical measurement of the ridge width as -2, -5 &amp; -8 mm from crest at the Region of interest (ROI) using a caliper</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in Ridge height mm</measure>
    <time_frame>baseline( prior to augmentation) and 9 months (implant placement)</time_frame>
    <description>Ridge height from a pre-determined landmark using a 15mm Dental probe</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Alveolar Ridge Augmentation, Dental Implants</condition>
  <arm_group>
    <arm_group_label>Ossix Volumax</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>lateral bone augmentation using volume maintaining collagen scaffold (Ossix Volumax)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FDBA with collagen membrane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>lateral bone augmentation using the current gold standard FDBA plus resorbable collagen membrane</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ossix Volumax</intervention_name>
    <description>Ossix Volumax is intended to be used for Lateral ridge augmentation</description>
    <arm_group_label>Ossix Volumax</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FDBA with collagen membrane</intervention_name>
    <description>freeze-dried bone allograft (FDBA) with collagen membrane</description>
    <arm_group_label>FDBA with collagen membrane</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients age 18 to 85 years of age.

          2. Alveolar ridge atrophy (&lt;5 mm) in the horizontal dimension requiring bone
             augmentation.

          3. Implant therapy is scheduled for this site.

          4. Willing to participate in the study and follow all the post-op visits.

        Exclusion Criteria:

          1. Systemic condition requiring prophylactic antibiotics.

          2. The Introduction( I.V.) use of medication related osteonecrosis of the jaw ( MRONJ) or
             the use of such medication Per Os (P.O.) for five or more years, patients with at
             least three month drug holiday with a C-terminal cross-linking telopeptide (CTX) &gt; 150
             pg/ml are eligible.

          3. The use of medication known to impair healing (clinician desecration).

          4. Unable to place implant for whatever reason.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eli Machtei, DMD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rambam Health Care Campus</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eli Machtei, DMD</last_name>
    <phone>9727772983</phone>
    <email>machtei@rambam.health.gov.il</email>
  </overall_contact>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 26, 2018</study_first_submitted>
  <study_first_submitted_qc>March 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 7, 2018</study_first_posted>
  <last_update_submitted>May 15, 2018</last_update_submitted>
  <last_update_submitted_qc>May 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

